Please enable JavaScript to continue using this application.

Compare $ABOS vs $NERV | Chartloom

Compare

$ABOS vs $NERV

Acumen Pharmaceuticals Inc · Minerva Neurosciences Inc

ABOS

Acumen Pharmaceuticals Inc

NERV

Minerva Neurosciences Inc

Compare $ABOS vs $NERV

Comparing Acumen Pharmaceuticals Inc and Minerva Neurosciences Inc

ABOSAcumen Pharmaceuticals Inc

NERVMinerva Neurosciences Inc

ABOSAcumen Pharmaceuticals Inc

Market cap

$155M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

5.9%

52W performance

13.8%

FCF yield

-59.4%

NERVMinerva Neurosciences Inc

Market cap

$148M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-18.9%

52W performance

12.4%

FCF yield

-17.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABOS

NERV

Detailed metrics comparison

ABOS

Acumen Pharmaceuticals Inc

NERV

Minerva Neurosciences Inc

Market Cap

ABOS$155M

NERV$148M

Enterprise Value

ABOS$127M

NERV$184M

Price

ABOS$2.14

NERV$3.18

P/E Ratio

ABOSN/A

NERVN/A

P/S Ratio

ABOS102.45x

NERV0.00x

EV/Sales

ABOS0.00x

NERV0.00x

EV/EBITDA

ABOS0.00x

NERV28.95x

P/B Ratio

ABOS2.58x

NERV19.58x

P/FCF Ratio

ABOSN/A

NERVN/A

EV/FCF

ABOS-1.38x

NERV-7.01x

PEG Ratio

ABOSN/A

NERVN/A

Forward P/E (NTM)

ABOSN/A

NERVN/A

Forward P/S (NTM)

ABOSN/A

NERVN/A

Revenue (TTM)

ABOS$0

NERV$0

Revenue Growth (YoY)

ABOSN/A

NERVN/A

Forward Rev Growth

ABOS1135.7%

NERV534.2%

Gross Margin (TTM)

ABOS0.0%

NERV0.0%

Operating Margin (TTM)

ABOS0.0%

NERV0.0%

EBITDA Margin (TTM)

ABOS0.0%

NERV0.0%

Net Margin (TTM)

ABOS0.0%

NERV0.0%

FCF Margin (TTM)

ABOSN/A

NERVN/A

Net Income (TTM)

ABOS$-105M

NERV$-395M

FCF (TTM)

ABOS$-92M

NERV$-26M

EPS (TTM)

ABOS-$1.45

NERV-$5.00

ROE (TTM)

ABOS-13627.0%

NERV-16962.0%

ROA (TTM)

ABOS-8164.0%

NERV-50048.0%

ROIC (TTM)

ABOS-9709.0%

NERV-16962.0%

Cash

ABOS$59M

NERV$25M

Debt

ABOS$32M

NERV$60M

Net Cash/Debt

ABOS$28M

NERV$-35M

Current Ratio (TTM)

ABOS2.47x

NERV20.14x

Quick Ratio (TTM)

ABOS2.38x

NERV19.04x

Debt/Equity (TTM)

ABOS0.55x

NERV0.00x

Debt/Assets (TTM)

ABOS0.0%

NERV0.0%

Interest Coverage (TTM)

ABOSN/A

NERVN/A

Net Debt/EBITDA (TTM)

ABOS0.00x

NERV0.00x

Beta

ABOS0.30

NERV0.04

52W Performance

ABOS13.8%

NERV12.4%

YTD Performance

ABOS5.9%

NERV-18.9%

% from 52W High

ABOS-40.6%

NERV-74.5%

% from 52W Low

ABOS42.7%

NERV42.1%

Asset Turnover (TTM)

ABOS0.00x

NERV0.00x

FCF Yield (TTM)

ABOS-59.4%

NERV-17.7%

Earnings Yield (TTM)

ABOS-68.0%

NERV-266.7%

Dividend Yield (TTM)

ABOSN/A

NERVN/A

Rule of 40

ABOS0.0

NERV0.0

EV/GP/RG

ABOSN/A

NERVN/A

Ticker research

View ABOS research View NERV research

Metric	ABOS Acumen Pharmaceuticals Inc	NERV Minerva Neurosciences Inc
Market & Valuation
Market Cap	$155M	$148M
Enterprise Value	$127M	$184M
Price	$2.14	$3.18
P/E Ratio	N/A	N/A
P/S Ratio	102.45x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	28.95x
P/B Ratio	2.58x	19.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.38x	-7.01x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1135.7%	534.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-105M	$-395M
FCF (TTM)	$-92M	$-26M
EPS (TTM)	-$1.45	-$5.00
ROE (TTM)	-13627.0%	-16962.0%
ROA (TTM)	-8164.0%	-50048.0%
ROIC (TTM)	-9709.0%	-16962.0%
Financial Health
Cash	$59M	$25M
Debt	$32M	$60M
Net Cash/Debt	$28M	$-35M
Current Ratio (TTM)	2.47x	20.14x
Quick Ratio (TTM)	2.38x	19.04x
Debt/Equity (TTM)	0.55x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.30	0.04
52W Performance	13.8%	12.4%
YTD Performance	5.9%	-18.9%
% from 52W High	-40.6%	-74.5%
% from 52W Low	42.7%	42.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-59.4%	-17.7%
Earnings Yield (TTM)	-68.0%	-266.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ABOS research	View NERV research

Valuation

P/S Ratio

NERV

0.00x

ABOS

102.45x

EV/FCF

NERV

-7.01x

ABOS

-1.38x

Growth & revenue

Forward Revenue Growth

ABOS

1135.7%

NERV

534.2%

Profitability & performance

Gross Margin

ABOS

0.0%

NERV

0.0%

ROE

ABOS

-13627.0%

NERV

-16962.0%

FCF Yield %

NERV

-17.7%

ABOS

-59.4%

52-Week Performance

ABOS

13.8%

NERV

12.4%

Detailed metrics comparison

ABOS

Acumen Pharmaceuticals Inc

NERV

Minerva Neurosciences Inc

Market Cap

ABOS$155M

NERV$148M

Enterprise Value

ABOS$127M

NERV$184M

Price

ABOS$2.14

NERV$3.18

P/E Ratio

ABOSN/A

NERVN/A

P/S Ratio

ABOS102.45x

NERV0.00x

EV/Sales

ABOS0.00x

NERV0.00x

EV/EBITDA

ABOS0.00x

NERV28.95x

P/B Ratio

ABOS2.58x

NERV19.58x

P/FCF Ratio

ABOSN/A

NERVN/A

EV/FCF

ABOS-1.38x

NERV-7.01x

PEG Ratio

ABOSN/A

NERVN/A

Forward P/E (NTM)

ABOSN/A

NERVN/A

Forward P/S (NTM)

ABOSN/A

NERVN/A

Revenue (TTM)

ABOS$0

NERV$0

Revenue Growth (YoY)

ABOSN/A

NERVN/A

Forward Rev Growth

ABOS1135.7%

NERV534.2%

Gross Margin (TTM)

ABOS0.0%

NERV0.0%

Operating Margin (TTM)

ABOS0.0%

NERV0.0%

EBITDA Margin (TTM)

ABOS0.0%

NERV0.0%

Net Margin (TTM)

ABOS0.0%

NERV0.0%

FCF Margin (TTM)

ABOSN/A

NERVN/A

Net Income (TTM)

ABOS$-105M

NERV$-395M

FCF (TTM)

ABOS$-92M

NERV$-26M

EPS (TTM)

ABOS-$1.45

NERV-$5.00

ROE (TTM)

ABOS-13627.0%

NERV-16962.0%

ROA (TTM)

ABOS-8164.0%

NERV-50048.0%

ROIC (TTM)

ABOS-9709.0%

NERV-16962.0%

Cash

ABOS$59M

NERV$25M

Debt

ABOS$32M

NERV$60M

Net Cash/Debt

ABOS$28M

NERV$-35M

Current Ratio (TTM)

ABOS2.47x

NERV20.14x

Quick Ratio (TTM)

ABOS2.38x

NERV19.04x

Debt/Equity (TTM)

ABOS0.55x

NERV0.00x

Debt/Assets (TTM)

ABOS0.0%

NERV0.0%

Interest Coverage (TTM)

ABOSN/A

NERVN/A

Net Debt/EBITDA (TTM)

ABOS0.00x

NERV0.00x

Beta

ABOS0.30

NERV0.04

52W Performance

ABOS13.8%

NERV12.4%

YTD Performance

ABOS5.9%

NERV-18.9%

% from 52W High

ABOS-40.6%

NERV-74.5%

% from 52W Low

ABOS42.7%

NERV42.1%

Asset Turnover (TTM)

ABOS0.00x

NERV0.00x

FCF Yield (TTM)

ABOS-59.4%

NERV-17.7%

Earnings Yield (TTM)

ABOS-68.0%

NERV-266.7%

Dividend Yield (TTM)

ABOSN/A

NERVN/A

Rule of 40

ABOS0.0

NERV0.0

EV/GP/RG

ABOSN/A

NERVN/A

Ticker research

View ABOS research View NERV research

Metric	ABOS Acumen Pharmaceuticals Inc	NERV Minerva Neurosciences Inc
Market & Valuation
Market Cap	$155M	$148M
Enterprise Value	$127M	$184M
Price	$2.14	$3.18
P/E Ratio	N/A	N/A
P/S Ratio	102.45x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	28.95x
P/B Ratio	2.58x	19.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.38x	-7.01x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1135.7%	534.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-105M	$-395M
FCF (TTM)	$-92M	$-26M
EPS (TTM)	-$1.45	-$5.00
ROE (TTM)	-13627.0%	-16962.0%
ROA (TTM)	-8164.0%	-50048.0%
ROIC (TTM)	-9709.0%	-16962.0%
Financial Health
Cash	$59M	$25M
Debt	$32M	$60M
Net Cash/Debt	$28M	$-35M
Current Ratio (TTM)	2.47x	20.14x
Quick Ratio (TTM)	2.38x	19.04x
Debt/Equity (TTM)	0.55x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.30	0.04
52W Performance	13.8%	12.4%
YTD Performance	5.9%	-18.9%
% from 52W High	-40.6%	-74.5%
% from 52W Low	42.7%	42.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-59.4%	-17.7%
Earnings Yield (TTM)	-68.0%	-266.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ABOS research	View NERV research